Stem cell therapies are improving recovery and survival rates for pediatric cancer patients. But the treatments can be risky. They can weaken the immune system, making children highly vulnerable to infections. And there are other potential long-term complications, including damage to tissues and organs.

A team of researchers at Georgia Tech has addressed this challenge, creating a new way to predict how these cutting-edge treatments might work in a particular patient. And it could revolutionize treatments for kids with complex immune system challenges.

Read full story here.